Showing 1 - 1 of 1 results
Class (Stereo):
CHEMICAL (RACEMIC)
Targets:
Conditions:
Sulfinpyrazone was approved by the U.S. Food and Drug Administration (FDA) on May 13, 1959. It was developed and marketed as Anturane® by Novartis. Sulfinpyrazone is an oral uricosuric agent (pyrazolone derivative) used to treat chronic or intermitte...